Holen Sie sich die Stockscreener-App
26.92
0.49%
0.13
Handel nachbörslich:
26.92
Schlusskurs vom Vortag:
$26.79
Offen:
$26.67
24-Stunden-Volumen:
785.60K
Relative Volume:
1.00
Marktkapitalisierung:
$2.21B
Einnahmen:
$1.93B
Nettoeinkommen (Verlust:
$174.22M
KGV:
13.12
EPS:
2.0516
Netto-Cashflow:
$237.32M
1W Leistung:
+0.60%
1M Leistung:
+13.78%
6M Leistung:
+20.50%
1J Leistung:
+98.53%
1-Tages-Spanne:
$26.31
$27.02
1-Wochen-Bereich:
$26.28
$27.94
52-Wochen-Spanne:
$11.84
$27.94
Pediatrix Medical Group Inc Stock (MD) Company Profile
Firmenname
Pediatrix Medical Group Inc
Sektor
Branche
Telefon
(954) 384-0175
Adresse
1301 CONCORD TERRACE, SUNRISE, FL
Compare MD vs HCA, THC, DVA, FMS, EHC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MD
Pediatrix Medical Group Inc
|
26.92 | 2.20B | 1.93B | 174.22M | 237.32M | 2.0516 |
HCA
Hca Healthcare Inc
|
409.01 | 91.09B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
206.77 | 17.77B | 21.46B | 2.65B | 3.35B | 19.23 |
DVA
Davita Inc
|
229.48 | 14.81B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
23.91 | 12.86B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
111.02 | 10.94B | 6.07B | 793.80M | 464.40M | 5.9914 |
Pediatrix Medical Group Inc Stock (MD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-16 | Eingeleitet | Macquarie | Outperform |
| 2024-09-26 | Hochstufung | Jefferies | Hold → Buy |
| 2024-06-07 | Hochstufung | Deutsche Bank | Sell → Hold |
| 2021-09-27 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2021-06-23 | Fortgesetzt | Stifel | Hold |
| 2020-10-19 | Herabstufung | Deutsche Bank | Hold → Sell |
| 2020-01-03 | Herabstufung | Citigroup | Buy → Neutral |
| 2019-12-12 | Hochstufung | Stifel | Hold → Buy |
| 2019-09-06 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2019-01-15 | Hochstufung | Citigroup | Neutral → Buy |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Hold |
| 2018-11-16 | Eingeleitet | UBS | Sell |
| 2018-09-24 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2018-09-18 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2018-08-03 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2018-07-12 | Eingeleitet | Leerink Partners | Mkt Perform |
| 2018-03-27 | Eingeleitet | Credit Suisse | Neutral |
| 2018-02-12 | Bestätigt | Mizuho | Neutral |
| 2017-12-13 | Eingeleitet | Piper Jaffray | Overweight |
| 2017-09-18 | Hochstufung | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2017-05-30 | Bestätigt | Mizuho | Neutral |
| 2017-05-25 | Bestätigt | Stifel | Hold |
| 2017-05-04 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2017-03-21 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2017-03-10 | Herabstufung | JP Morgan | Overweight → Neutral |
Alle ansehen
Pediatrix Medical Group Inc Aktie (MD) Neueste Nachrichten
Does Pediatrix (MD) Joining Russell Defensive Indexes Recast Its Profile as a Value-Safe Haven? - simplywall.st
Pediatrix Medical Group stock hits 52-week high at 25.02 USD - Investing.com South Africa
ETFs Investing in Pediatrix Medical Group, Inc. Stocks - TradingView
Pediatrix Medical Group (MD) is a top-ranked growth stock: Should you buy? - MSN
Pediatrix Medical Group, Inc.(NYSE: MD) added to Russell 2000 Value-Defensive Index - marketscreener.com
Pediatrix Medical Group, Inc.(NYSE: MD) added to Russell 2000 Defensive Index - marketscreener.com
Pediatrix Medical Group (MD) Slips 0.7% as Stock Tests Key Support LevelShort Setup Alerts - dars.gov.et
Pediatrix Medical Group, Inc. Actuals & Estimates (NYSE:MD) - TradingView
MD Forecast — Price Target — Prediction for 2027 - TradingView
Price to earnings forward of Pediatrix Medical Group, Inc. – NYSE:MD - TradingView
Enterprise value to EBITDA forward of Pediatrix Medical Group, Inc. – NYSE:MD - TradingView
Is Ongoing Sales Weakness and Softer Returns Reshaping the Investment Case For Pediatrix (MD)? - Sahm
Form 4 Pediatrix Medical Group Inc For: 24 June By Investing.com - Investing.com South Africa
[Form 4] Pediatrix Medical Group, Inc. Insider Trading Activity - Stock Titan
Pediatrix (MD) EVP and General Counsel David Haddock submits initial Form 3 - Stock Titan
Here's why Pediatrix Medical Group (MD) is a strong momentum stock - MSN
Pediatrix Medical Group Inc (NYSE:MD): A Decent Value Play in a Bull Market - ChartMill
Pediatrix Medical Group Inc (MD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Pediatrix Medical Group StockLong-term strategy and business model in focus - AD HOC NEWS
Pediatrix Medical Group Inc (MD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Pediatrix Medical Group Inc (MD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Pediatrix Medical Group Inc (MD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Pediatrix Medical Group Inc (MD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Pediatrix Medical Group Inc (MD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Pediatrix Medical Group Inc (MD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Pediatrix Medical Group Inc (MD) Valuation: PE, PB & Fair Value Analysis - TradingKey
New pediatric telehealth push, MD Telemedicine expands Pediatrix’s virtual reach - Ad-hoc-news.de
Boston Partners Small Cap Value Fund II's Pediatrix Medical Group Inc(MD) Holding History - GuruFocus
Pediatrix Medical Group (MD) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Here's why Pediatrix Medical Group (MD) is a strong growth stock - MSN
Pediatrix (MD) EVP Mary Ann Moore reports 36,814-share bona fide stock gifts - Stock Titan
Pediatrix Medical Group Q1 2026 Earnings: EPS Surges Past Expectations, Stock Jumps 5.3%Revenue Recognition Risk - newsline.com
Why Is Pediatrix Medical Group (MD) Down 1.7% Since Last Earnings Report? - Yahoo Finance
Pediatrix Medical (MD) Highlights Probiotic Research Impact on P - GuruFocus
Pediatrix Medical Group Announces Publication of New Research Addressing Urgent Questions in Neonatology - 01net
Articles from Pediatrix Medical Group - FinancialContent
Pediatrix Medical Group Study Evaluates NICU Protocols for Respiratory, Nutritional, and Infection Management - geneonline.com
Pediatrix (MD) CFO receives 31,800 restricted shares with multi-year vesting - Stock Titan
Pediatrix (MD) CEO reshapes restricted stock awards while retaining 313,710 shares - Stock Titan
Pediatrix (MD) EVP uses 11,944 vested shares to cover tax withholding - Stock Titan
Pediatrix Medical Group (MD) Edges Higher as Stock Holds Above Key SupportFibonacci Time Zone - newsline.com
Q1 Earnings Roundup: Pediatrix Medical Group (NYSE:MD) And The Rest Of The Healthcare Providers & Services Segment - Yahoo Finance
Assessing Pediatrix Medical Group (MD) Valuation As Shares Show Mixed Short Term Momentum - Yahoo Finance
Pediatrix Medical Group Shares Surge After Beating Q1 2026 Revenue Estimates - HarianBasis.co
Why Pediatrix Medical Group (MD) is a top momentum stock for the long term - MSN
Pediatrix Medical Group Q1 2026 earnings preview - MSN
Pediatrix Medical Group Reaffirms EBITDA Outlook on Call - TipRanks
Does Pediatrix Medical Group (MD) Stock Look Better After Q1 Report? - Insider Monkey
Pediatrix Medical Group (MD) Holds Steady: A Quiet Session Near Key SupportSign of Weakness - The Legal Advocate
Pediatrix Medical Group (MD) Holds Steady Near Resistance: Consolidation Phase Ahead?Last Point Support - newsline.com
MDPediatrix Medical Group Inc Stock Price and Quote - Finviz
Finanzdaten der Pediatrix Medical Group Inc-Aktie (MD)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.86%
0.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):